Usage of Eltrombopag for Chronic Immune Thrombocytopenia as a Pretreatment for Splenectomy

Publisher： Karger

E-ISSN： 1421-9662|129|1|45-47

ISSN： 0001-5792

Source： Acta Haematologica, Vol.129, Iss.1, 2012-10, pp. : 45-47

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Eltrombopag with i.v. immunoglobulin for safe splenectomy in refractory immune thrombocytopenia

By  

PEDIATRICS INTERNATIONAL, Vol. 60, Iss. 2, 2018-02 ,pp. : 191-192

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of bone marrow reticulin in patients with chronic immune thrombocytopenia treated with eltrombopag: Data from the EXTEND study

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 7, 2015-07 ,pp. : 598-601

John Wiley & Sons Inc

Access to resources Recommend Favorite

A 2-Year, Longitudinal, Prospective Study of the Effects of Eltrombopag on Bone Marrow in Patients with Chronic Immune Thrombocytopenia

By  

Acta Haematologica, Vol. 137, Iss. 2, 2016-12 ,pp. : 66-72

Karger

Access to resources Recommend Favorite

Use of eltrombopag after romiplostim in primary immune thrombocytopenia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 169, Iss. 1, 2015-04 ,pp. : 111-116

John Wiley & Sons Inc

Access to resources Recommend Favorite

Is There a Role for Low-Dose Eltrombopag as Maintenance Therapy in the Treatment of Immune Thrombocytopenia?

By  

Acta Haematologica, Vol. 133, Iss. 1, 2014-08 ,pp. : 78-82

Karger

Access to resources Recommend Favorite